000 01456 a2200397 4500
005 20250517094632.0
264 0 _c20170130
008 201701s 0 0 eng d
022 _a1875-2128
024 7 _a10.1016/j.acvd.2016.02.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBobin, Pierre
245 0 0 _aCyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
_h[electronic resource]
260 _bArchives of cardiovascular diseases
_c
300 _a431-43 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBlood Vessels
_xdrug effects
650 0 4 _aCardiovascular Agents
_xadverse effects
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMyocardium
_xenzymology
650 0 4 _aPhosphodiesterase Inhibitors
_xadverse effects
650 0 4 _aPhosphoric Diester Hydrolases
_xmetabolism
650 0 4 _aSecond Messenger Systems
_xdrug effects
700 1 _aBelacel-Ouari, Milia
700 1 _aBedioune, Ibrahim
700 1 _aZhang, Liang
700 1 _aLeroy, Jérôme
700 1 _aLeblais, Véronique
700 1 _aFischmeister, Rodolphe
700 1 _aVandecasteele, Grégoire
773 0 _tArchives of cardiovascular diseases
_gvol. 109
_gno. 6-7
_gp. 431-43
856 4 0 _uhttps://doi.org/10.1016/j.acvd.2016.02.004
_zAvailable from publisher's website
999 _c26024927
_d26024927